查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602231

关节内粘稠补充疗法市场：按产品、来源、应用和最终用途 - 全球预测 2025-2030

Viscosupplementation Market by Product (Five Injection, Single Injection, Three Injection), Source (Animal, Non-animal), Application, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年关节内粘稠补充疗法市场价值为28.3亿美元，预计到2024年将达到30.1亿美元，复合年增长率为6.19%，预计到2030年将达到43.2亿美元。

关节内粘稠补充疗法是一种将透明质酸注射到关节中以缓解疼痛并改善活动能力的医疗程序，主要针对骨关节炎患者。需要关节内粘稠补充疗法是因为当传统治疗方法不足时，它可以提供显着的缓解，并且可以作为手术选择之前的中间解决方案。它的用途主要用于整形外科治疗，特别是膝骨关节炎，但其用途也已扩展到髋关节、踝关节和肩关节。最终用途范围从医院和诊所到门诊手术中心，反映了其在各种医疗保健环境中的适应性。市场成长的主要驱动力是全球人口老化、骨关节炎盛行率上升以及对非手术治疗选择的认识不断提高。透明质酸配方的技术进步以及对微创手术的日益关注将进一步刺激需求。亚太地区等开拓的新兴市场存在机会，这些地区医疗基础设施的改善正在促进市场进入。在开发提供卓越功效的更持久的配方和递送方法方面存在跨领域的机会。然而，关节内粘稠补充疗法也存在局限性，包括成本和不一致的报销政策，以及患者反应变化和来自皮质类固醇和富血小板血浆疗法等替代疗法的竞争等挑战。创新和研究应集中在新的递送平台上，例如缓释性透明质酸产品和结合发炎药物以增强治疗效果的联合治疗。市场竞争激烈、发展迅速，迫使产业参与者不断创新，适应不断变化的监管环境和客户期望。公司应利用数位管道向医疗保健专业人员和患者宣传治疗的好处并提高采用率。优先考虑以患者为中心的研究和扩大临床适应症对于未来市场的成功至关重要。

主要市场统计
基准年[2023] 28.3亿美元
预测年份 [2024] 30.1亿美元
预测年份 [2030] 43.2亿美元
复合年增长率（%） 6.19%

市场动态：快速发展的关节内粘稠补充疗法市场的关键市场洞察

供需的动态交互作用正在改变关节内粘稠补充疗法市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 骨关节炎非手术治疗的需求不断增长
    • 饮食习惯改变导致文明病增加
    • 世界人口老化和肥胖症迅速增加
  • 市场限制因素
    • 透明质酸治疗的副作用和高成本
  • 市场机会
    • 基于透明质酸的治疗方法的开发不断取得进展
    • 扩大关节内粘稠补充疗法在髌骨软骨病变中的作用
  • 市场挑战
    • 核准规定严格，润滑镇痛作用持续时间短

波特五力：引领关节内粘稠补充疗法市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解关节内粘稠补充疗法市场的外部影响

外部宏观环境因素在塑造关节内粘稠补充疗法市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解关节内粘稠补充疗法市场的竞争格局

对关节内粘稠补充疗法市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵关节内粘稠补充疗法市场供应商的绩效评估

FPNV定位矩阵是评估关节内粘稠补充疗法市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 骨关节炎非手术治疗的需求不断增加
      • 饮食习惯的改变导致文明病的发生率增加
      • 全球老年人口和肥胖症迅速增加
    • 抑制因素
      • 透明质酸治疗的副作用和高成本
    • 机会
      • 基于透明质酸的治疗方法的开发不断取得进展
      • 扩大关节内粘稠补充疗法在髌骨软骨病变中的作用
    • 任务
      • 核准严格、润滑镇痛持续时间短的监理要求
  • 市场区隔分析
    • 产品：三重註射疗法的采用激增，以减轻骨关节炎患者的疼痛并增加活动能力
    • 资料来源：越来越偏好非动物源性透明质酸以消除过敏反应的风险
    • 应用：关节内粘稠补充疗法治疗膝骨关节炎的不断发展的应用
    • 最终用途：扩大关节内粘稠补充疗法在整形外科诊所/门诊手术中心（ASC）的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第六章关节内粘稠补充疗法市场：依产品

  • 5次注射
  • 单次注射
  • 3次注射

第七章关节内粘稠补充疗法市场：依来源分类

  • 动物
  • 非动物的

第八章关节内粘稠补充疗法市场：依应用分类

  • 手骨关节炎
  • 髋骨关节炎
  • 膝骨关节炎

第九章关节内粘稠补充疗法市场：依最终用途分类

  • 医院
  • 整形外科诊所/门诊手术中心 (ASC)

第十章北美和南美关节内粘稠补充疗法市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太关节关节内粘稠补充疗法市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲关节内粘稠补充疗法市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • KiOmed Pharma 和 Arsylab 宣布建立战略合作伙伴关係，在法国促销和分销 KioMedinevsone，这是一种治疗难治性膝骨关节炎的新疗法
    • Anika 的 Shingal 在 3 期试验中达到主要终点

公司名单

  • Avanos Medical, Inc.
  • Viatris Inc.
  • LG Chem Ltd.
  • Anika Therapeutics, Inc.
  • Quimfa SA
  • Sanofi SA
  • Contipro AS
  • Lifecore Biomedical, LLC
  • Smith & Nephew PLC
  • Bioventus LLC
  • Fidia Farmaceutici SpA
  • Alcon Inc.
  • Seikagaku Corporation
  • Teva Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Ferring BV
  • Zimmer Biomet
  • Regen Lab SA
  • Gentex Pharma, LLC
  • Bausch Health Companies Inc.
  • AbbVie Inc.
  • DePuy Synthes by Johnson & Johnson Services, Inc.
Product Code: MRR-0315DDADCE1F

The Viscosupplementation Market was valued at USD 2.83 billion in 2023, expected to reach USD 3.01 billion in 2024, and is projected to grow at a CAGR of 6.19%, to USD 4.32 billion by 2030.

Viscosupplementation is a medical procedure involving the injection of hyaluronic acid into joints to alleviate pain and improve mobility, primarily for those with osteoarthritis. The necessity of viscosupplementation arises due to its potential to provide significant relief where conventional therapies may not suffice, acting as an intermediate solution before surgical options. Its application is mainly in orthopedic care, particularly for knee osteoarthritis, although research is expanding its use to hip, ankle, and shoulder joints as well. End-use spans from hospitals and clinics to ambulatory surgical centers, reflecting its adaptability in various healthcare settings. Market growth is chiefly driven by the aging global population, the rising prevalence of osteoarthritis, and increasing awareness of non-surgical treatment alternatives. Technological advancements in hyaluronic acid formulations and the growing focus on minimally invasive procedures further stimulate demand. Opportunities lie in untapped emerging markets like Asia-Pacific, where improving healthcare infrastructure is fostering market entry. There is a cross-sectional opportunity in developing enhanced, longer-lasting formulations and delivery methods that could provide superior efficacy. However, limitations include the cost of viscosupplementation and inconsistent reimbursement policies, while challenges include variability in patient response and competition from alternative treatments like corticosteroids and platelet-rich plasma therapies. Innovation and research should focus on novel delivery platforms, such as sustained-release hyaluronic acid products or combination therapies that incorporate anti-inflammatory agents to enhance treatment outcomes. The market is characterized by strong competition and rapid advancements, thus industry players must continuously innovate and adapt to shifting regulatory scenarios and customer expectations. Companies should leverage digital channels to educate healthcare professionals and patients on treatment benefits to drive adoption. Prioritizing patient-centric research and expanding clinical indications will be crucial for future market success.

KEY MARKET STATISTICS
Base Year [2023] USD 2.83 billion
Estimated Year [2024] USD 3.01 billion
Forecast Year [2030] USD 4.32 billion
CAGR (%) 6.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Viscosupplementation Market

The Viscosupplementation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing Need for Non-Surgical Treatment for Osteoarthritis
    • Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
    • Surge in Geriatric Population and Obesity Globally
  • Market Restraints
    • Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
  • Market Opportunities
    • Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
    • Extending Role of Viscosupplementation in Patellar Chondropathy
  • Market Challenges
    • Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief

Porter's Five Forces: A Strategic Tool for Navigating the Viscosupplementation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Viscosupplementation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Viscosupplementation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Viscosupplementation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Viscosupplementation Market

A detailed market share analysis in the Viscosupplementation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Viscosupplementation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Viscosupplementation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Viscosupplementation Market, highlighting leading vendors and their innovative profiles. These include Avanos Medical, Inc., Viatris Inc., LG Chem Ltd., Anika Therapeutics, Inc., Quimfa S.A., Sanofi S.A., Contipro A.S., Lifecore Biomedical, LLC, Smith & Nephew PLC, Bioventus LLC, Fidia Farmaceutici S.p.A., Alcon Inc., Seikagaku Corporation, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Ferring B.V., Zimmer Biomet, Regen Lab SA, Gentex Pharma, LLC, Bausch Health Companies Inc., AbbVie Inc., and DePuy Synthes by Johnson & Johnson Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Viscosupplementation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Five Injection, Single Injection, and Three Injection.
  • Based on Source, market is studied across Animal and Non-animal.
  • Based on Application, market is studied across Hand Osteoarthritis, Hip Osteoarthritis, and Knee Osteoarthritis.
  • Based on End-use, market is studied across Hospitals and Orthopedic Clinics/Ambulatory Surgical Centers (ASCs).
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Need for Non-Surgical Treatment for Osteoarthritis
      • 5.1.1.2. Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
      • 5.1.1.3. Surge in Geriatric Population and Obesity Globally
    • 5.1.2. Restraints
      • 5.1.2.1. Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
      • 5.1.3.2. Extending Role of Viscosupplementation in Patellar Chondropathy
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Products: Burgeoning adoption of a three-injection regimen to reduce pain and enhance mobility in patients with osteoarthritis
    • 5.2.2. Source: Growing preference for non-animal-based hyaluronic acid as it eliminates hypersensitivity reaction risks
    • 5.2.3. Applications: Evolving applications of viscosupplementation treatment for knee osteoarthritis
    • 5.2.4. End-use: Proliferating utilization of viscosupplementation treatment in orthopedic clinics/ambulatory surgical centers (ASCs)
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Viscosupplementation Market, by Product

  • 6.1. Introduction
  • 6.2. Five Injection
  • 6.3. Single Injection
  • 6.4. Three Injection

7. Viscosupplementation Market, by Source

  • 7.1. Introduction
  • 7.2. Animal
  • 7.3. Non-animal

8. Viscosupplementation Market, by Application

  • 8.1. Introduction
  • 8.2. Hand Osteoarthritis
  • 8.3. Hip Osteoarthritis
  • 8.4. Knee Osteoarthritis

9. Viscosupplementation Market, by End-use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)

10. Americas Viscosupplementation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Viscosupplementation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Viscosupplementation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. KiOmed Pharma and Arsylab Announce Strategic Partnership for the Promotion and Distribution in France of KioMedinevsone, a New Class of Treatment for Refractory Knee Osteoarthritis
    • 13.3.2. Anika's Cingal Successfully Achieves Primary Endpoint in Third Phase III Study

Companies Mentioned

  • 1. Avanos Medical, Inc.
  • 2. Viatris Inc.
  • 3. LG Chem Ltd.
  • 4. Anika Therapeutics, Inc.
  • 5. Quimfa S.A.
  • 6. Sanofi S.A.
  • 7. Contipro A.S.
  • 8. Lifecore Biomedical, LLC
  • 9. Smith & Nephew PLC
  • 10. Bioventus LLC
  • 11. Fidia Farmaceutici S.p.A.
  • 12. Alcon Inc.
  • 13. Seikagaku Corporation
  • 14. Teva Pharmaceutical Industries Ltd.
  • 15. F. Hoffmann-La Roche Ltd.
  • 16. Ferring B.V.
  • 17. Zimmer Biomet
  • 18. Regen Lab SA
  • 19. Gentex Pharma, LLC
  • 20. Bausch Health Companies Inc.
  • 21. AbbVie Inc.
  • 22. DePuy Synthes by Johnson & Johnson Services, Inc.

LIST OF FIGURES

  • FIGURE 1. VISCOSUPPLEMENTATION MARKET RESEARCH PROCESS
  • FIGURE 2. VISCOSUPPLEMENTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VISCOSUPPLEMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VISCOSUPPLEMENTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON-ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2023